GoAI
Get started
BeyondSpring Inc. logo

BeyondSpring Inc.

BYSI

NASDAQHealthcareBiotechnology

Open in GoAI

Previous close

$0.7201

$0.00 · 0.00%

Aug 21, 4:00 PM ET

BYSI company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

30

Expensive

Momentum

33

Weakening

Sentiment

53

Mixed

Risk resilience

35

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Industry
Biotechnology
Sector
Healthcare
Headquarters
US

Market position

Day range

Current $0.7201

52-week range

Current $0.7201

Open
$0.7201
Previous close
$0.7201
Volume
59.43K
Market cap
29.61M USD
50-day average
$1.2773
-43.62% below average
200-day average
$1.5767
-54.33% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

P/E (TTM)
-4.36×
P/B (TTM)
-0.83×
P/S (TTM)
0×
Dividend yield
0.00%

Profitability & efficiency

Gross margin
0.00%
Operating margin
0.00%
Net margin
0.00%

Financial health

Debt / equity
-0×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends600%-1401%-3402%-5403%Gross margin, FY2021: 100.00%Gross margin, FY2022: 100.00%Operating margin, FY2021: -4903.03%Operating margin, FY2022: -2756.40%Net margin, FY2021: -4750.48%Net margin, FY2022: -2463.29%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 100.00%. Gross margin FY2022 100.00%. Operating margin FY2021 -4903.03%. Operating margin FY2022 -2756.40%. Net margin FY2021 -4750.48%. Net margin FY2022 -2463.29%.

Income trends

Revenue

1.35M USD0.00%

Operating income

−8.95M USD-2.18%

Net income

−7.99M USD+28.15%
Income trends across reported periods8.11M USD−18.93M USD−45.96M USD−73M USDRevenue, FY2021: 1.35M USDRevenue, FY2022: 1.35M USDOperating income, FY2021: −66.24M USDOperating income, FY2022: −37.24M USDOperating income, FY2023: −15.08M USDOperating income, FY2024: −8.75M USDOperating income, FY2025: −8.95M USDNet income, FY2021: −64.18M USDNet income, FY2022: −33.28M USDNet income, FY2023: −21.03M USDNet income, FY2024: −11.12M USDNet income, FY2025: −7.99M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 1.35M USD. Revenue FY2022 1.35M USD. Operating income FY2021 −66.24M USD. Operating income FY2022 −37.24M USD. Operating income FY2023 −15.08M USD. Operating income FY2024 −8.75M USD. Operating income FY2025 −8.95M USD. Net income FY2021 −64.18M USD. Net income FY2022 −33.28M USD. Net income FY2023 −21.03M USD. Net income FY2024 −11.12M USD. Net income FY2025 −7.99M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue———1.35M USD1.35M USD
Cost of goods sold87K USD—302K USD——
Gross profit−87K USD—−302K USD1.35M USD1.35M USD
Research and development4.39M USD2.64M USD7.27M USD25.58M USD36.89M USD
Selling, general, and administrative4.56M USD6.11M USD7.51M USD13.01M USD30.7M USD
Operating expenses8.86M USD8.75M USD14.78M USD38.59M USD67.59M USD
Interest income78K USD59K USD421K USD195K USD98K USD
Interest expense———17K USD87K USD
Depreciation and amortization87K USD285K USD302K USD1.14M USD61K USD
Operating income−8.95M USD−8.75M USD−15.08M USD−37.24M USD−66.24M USD
Net income−7.99M USD−11.12M USD−21.03M USD−33.28M USD−64.18M USD

Company facts updated Aug 24, 2026.

BYSI peers

Amgen Inc. logo

AMGN

Amgen Inc.

$439.33

+1.29%

Gilead Sciences, Inc. logo

GILD

Gilead Sciences, Inc.

$146.12

+1.87%

Vertex Pharmaceuticals Incorporated logo

VRTX

Vertex Pharmaceuticals Incorporated

$548.05

+1.44%

Intuitive Surgical, Inc. logo

ISRG

Intuitive Surgical, Inc.

$378.81

+1.16%

Sanofi logo

SNY

Sanofi

$45.85

+1.55%

Regeneron Pharmaceuticals, Inc. logo

REGN

Regeneron Pharmaceuticals, Inc.

$834.04

+0.90%

ETFs holding BYSI

Funds reporting this stock among their holdings, ordered by reported position size.

Vanguard Morningstar Total Stock Market ETF logoVanguard Morningstar Total Stock Market ETFVTI
Market value
404.91K
Weight
0.00%
AUM
2.3T USD
Expense ratio
0.03%
Price / 1D
$378.24+0.44%
Vanguard Extended Market ETF logoVanguard Extended Market ETFVXF
Market value
394.58K
Weight
0.00%
AUM
93.7B USD
Expense ratio
0.05%
Price / 1D
$245.53+0.82%
iShares Micro-Cap ETF logoiShares Micro-Cap ETFIWC
Market value
92.23K
Weight
0.01%
AUM
1.53B USD
Expense ratio
0.60%
Price / 1D
$198.39+1.10%

Continue in GoAI

Research BYSI

research.disclaimer